Review: PET imaging with macro- and middle-sized molecular probes

Recent progress in radiolabeling of macro- and middle-sized molecular probes has been extending possibilities to use PET molecular imaging for dynamic application to drug development and therapeutic evaluation. Theranostics concept also accelerated the use of macro- and middle-sized molecular probes for sharpening the contrast of proper target recognition even the cellular types/subtypes and proper selection of the patients who should be treated by the same molecules recognition. Here, brief summary of the present status of immuno-PET, and then further development of advanced technologies related to immuno-PET, peptidic PET probes, and nucleic acids PET probes are described. (C) 2020 Elsevier Inc. All rights reserved.

Automated summary

Recent progress in radiolabeling of macro- and middle-sized molecular probes has expanded the possibilities of using PET molecular imaging in drug development and therapeutic evaluation, improving the accuracy of target recognition and patient selection. Current focus is on immuno-PET and related technologies.